881 related articles for article (PubMed ID: 32422340)
21. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity.
Molodtsov A; Turk MJ
Front Immunol; 2018; 9():2810. PubMed ID: 30555481
[TBL] [Abstract][Full Text] [Related]
22. Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8
Gauthier L; Corgnac S; Boutet M; Gros G; Validire P; Bismuth G; Mami-Chouaib F
Cancer Res; 2017 Dec; 77(24):7072-7082. PubMed ID: 29021139
[TBL] [Abstract][Full Text] [Related]
23. Resident Memory T Cells in the Tumor Microenvironment.
Williams JB; Kupper TS
Adv Exp Med Biol; 2020; 1273():39-68. PubMed ID: 33119875
[TBL] [Abstract][Full Text] [Related]
24. Discipline in Stages: Regulating CD8
Mora-Buch R; Bromley SK
Front Immunol; 2020; 11():624199. PubMed ID: 33815352
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Banchereau R; Chitre AS; Scherl A; Wu TD; Patil NS; de Almeida P; Kadel Iii EE; Madireddi S; Au-Yeung A; Takahashi C; Chen YJ; Modrusan Z; McBride J; Nersesian R; El-Gabry EA; Robida MD; Hung JC; Kowanetz M; Zou W; McCleland M; Caplazi P; Eshgi ST; Koeppen H; Hegde PS; Mellman I; Mathews WR; Powles T; Mariathasan S; Grogan J; O'Gorman WE
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827905
[TBL] [Abstract][Full Text] [Related]
26. CD8
Wu X; Wu P; Shen Y; Jiang X; Xu F
Front Immunol; 2018; 9():2093. PubMed ID: 30283442
[TBL] [Abstract][Full Text] [Related]
27. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells.
Sullivan PM; Reed SJ; Kalia V; Sarkar S
Front Immunol; 2021; 12():706150. PubMed ID: 34867942
[TBL] [Abstract][Full Text] [Related]
28. Fatty Acid Oxidation Controls CD8
Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral CD8
Virassamy B; Caramia F; Savas P; Sant S; Wang J; Christo SN; Byrne A; Clarke K; Brown E; Teo ZL; von Scheidt B; Freestone D; Gandolfo LC; Weber K; Teply-Szymanski J; Li R; Luen SJ; Denkert C; Loibl S; Lucas O; Swanton C; Speed TP; Darcy PK; Neeson PJ; Mackay LK; Loi S
Cancer Cell; 2023 Mar; 41(3):585-601.e8. PubMed ID: 36827978
[TBL] [Abstract][Full Text] [Related]
30. Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire tissue-resident memory like properties.
Mazzoni A; Maggi L; Montaini G; Ramazzotti M; Capone M; Vanni A; Locatello LG; Barra G; De Palma R; Gallo O; Cosmi L; Liotta F; Annunziato F
Eur J Immunol; 2020 Oct; 50(10):1571-1579. PubMed ID: 32441311
[TBL] [Abstract][Full Text] [Related]
31. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
32. Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression.
Egilmez NK; Kilinc MO
Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):399-405. PubMed ID: 20872283
[TBL] [Abstract][Full Text] [Related]
33. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
[TBL] [Abstract][Full Text] [Related]
34. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
Satooka H; Ishigaki H; Todo K; Terada K; Agata Y; Itoh Y; Ogasawara K; Hirata T
Sci Rep; 2020 May; 10(1):8414. PubMed ID: 32439888
[TBL] [Abstract][Full Text] [Related]
35. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.
Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027
[TBL] [Abstract][Full Text] [Related]
36. Tissue-resident memory T cells in breast cancer control and immunotherapy responses.
Byrne A; Savas P; Sant S; Li R; Virassamy B; Luen SJ; Beavis PA; Mackay LK; Neeson PJ; Loi S
Nat Rev Clin Oncol; 2020 Jun; 17(6):341-348. PubMed ID: 32112054
[TBL] [Abstract][Full Text] [Related]
37. HLA-G/LILRBs: A Cancer Immunotherapy Challenge.
Carosella ED; Gregori S; Tronik-Le Roux D
Trends Cancer; 2021 May; 7(5):389-392. PubMed ID: 33563576
[TBL] [Abstract][Full Text] [Related]
38. Implication of CD69
Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
[TBL] [Abstract][Full Text] [Related]
39. TGF-β: Many Paths to CD103
Qiu Z; Chu TH; Sheridan BS
Cells; 2021 Apr; 10(5):. PubMed ID: 33922441
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional programming of tissue-resident memory CD8
Milner JJ; Goldrath AW
Curr Opin Immunol; 2018 Apr; 51():162-169. PubMed ID: 29621697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
